These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 14685016

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism.
    Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3102-7. PubMed ID: 17550962
    [Abstract] [Full Text] [Related]

  • 43. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.
    Meikle AW.
    Clin Endocrinol (Oxf); 1982 Apr; 16(4):401-8. PubMed ID: 7094363
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Spot determinations of urinary cortisol for the screening of Cushing's syndrome.
    Fujita H, Hata K, Ogata E, Kojima I.
    Endocrinol Jpn; 1991 Aug; 38(4):441-4. PubMed ID: 1802685
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Intestinal Perforation in ACTH-Dependent Cushing's Syndrome.
    Shahidi M, Phillips RA, Chik CL.
    Biomed Res Int; 2019 Aug; 2019():9721781. PubMed ID: 31001560
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pseudo-Cushing's syndrome: an example of alcohol-induced central disorder in corticotropin-releasing factor-ACTH release?
    Proto G, Barberi M, Bertolissi F.
    Drug Alcohol Depend; 1985 Nov; 16(2):111-5. PubMed ID: 3000719
    [Abstract] [Full Text] [Related]

  • 56. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome.
    Atkinson AB, McAteer EJ, Hadden DR, Kennedy L, Sheridan B, Traub AI.
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):753-9. PubMed ID: 2728813
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Plasma 6beta-hydroxycortisol measurements for assessing altered hepatic drug metabolizing enzyme activity.
    Szücs N, Varga I, Patócs A, Tóth M, Jakab C, Gláz E, Rácz K.
    Acta Physiol Hung; 2003 Jun; 90(3):217-23. PubMed ID: 14594192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.